long intergenic non-protein coding RNA 2671Genealiases: []
Q-omics provides the consensus-scored LINC02671 profile across patient tissues and cancer cell-line models. LINC02671 expression is associated with patient survival in 20 of 34 cancer types, with the highest sampling consensus in THCA. Among the 18 cancer types available for tumor–normal comparison, LINC02671 is differentially expressed in 8, with the highest sampling consensus in KICH. Additionally, LINC02671 RNA expression shows 7,018 significant pathway-activity associations, with the highest sampling consensus in STAD. Together, these results highlight THCA, KICH, and STAD as cancer lineages where LINC02671 shows reproducible signals across survival, tumor–normal expression, and patient cross-omics analyses.
Every result is evaluated using two consensus scores. Sampling consensus measures how consistently a finding is reproduced within a cancer lineage across different conditions. Lineage consensus measures how broadly the result is shared across cancer types, distinguishing pan-cancer signals from lineage-specific patterns.
Premium analyses for LINC02671 — synthetic lethality, tumor antigen, and pembrolizumab response.
This table summarizes LINC02671 survival associations across molecular data types. LINC02671 RNA expression shows survival associations in the most cancer types (20). The rightmost column indicates the cancer type with the highest sampling consensus for each molecular layer.
This table ranks reproducible LINC02671 RNA expression–survival associations across cancer types. High LINC02671 expression shows unfavorable associations in THCA and KIRP, but favorable associations in ACC, UCS, KIRC and SKCM. The THCA Kaplan–Meier curve shows clear separation, with the high-expression group declining faster, consistent with the unfavorable association (log-rank p < 0.001). Together, the overview and detailed table identify THCA as the clearest survival context for LINC02671 RNA expression.
This table summarizes LINC02671 tumor–normal expression differences by data type. RNA shows broader differences across cancer types, with a lineage consensus of 8. The strongest signals are observed in THCA for RNA.
This table ranks reproducible tumor–normal expression differences for LINC02671. A negative fold-change indicates higher expression in normal tissue than in tumor tissue. LINC02671 shows lower tumor expression in KICH, THCA, KIRP, LIHC and CHOL and higher tumor expression in UCEC. The KICH box plot shows higher LINC02671 RNA expression in normal versus tumor tissue (log2 FC = −0.288, t-test p < 0.001).
This table shows molecular features associated with LINC02671 in patient tissues and cancer cell lines. In patient samples, LINC02671 shows the broadest associations at the RNA and protein expression levels, with STAD recurring as the lineage with the largest associated feature set.
